[Bazex paraneoplastic acrokeratosis. Treatment with acitretin]

Ann Dermatol Venereol. 1995;122(1-2):26-9.
[Article in French]

Abstract

Introduction: Bazex paraneoplastic acrokeratosis remains a therapeutic challenge when the cancer cannot be treated. We report the third patient in which a complete clearance of the lesions was obtained with oral acitretine.

Case report: A 67 year-old patient had Bazex paraneoplastic acrokeratosis. Despite a complete cancer screening, no cancer was found. A cervical lymph node metastasis was treated with surgery and radiotherapy. Because the cutaneous lesions got worse after this treatment, the patient received oral acitretine. A complete clearing of the lesions was observed within 2 months.

Discussion: Only 2 similar cases have been reported to our knowledge. The comparison with these 2 cases supports the efficacy of oral retinoids in this disease. The search and the treatment of the cancer remain compulsory.

Conclusion: In some definite cases, oral retinoids can be proposed as a treatment of cutaneous lesions in Bazex paraneoplastic acrokeratosis.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Acitretin / therapeutic use*
  • Acrodermatitis / drug therapy*
  • Aged
  • Head and Neck Neoplasms / complications
  • Humans
  • Keratosis / drug therapy*
  • Lymphatic Metastasis
  • Male
  • Paraneoplastic Syndromes / drug therapy*
  • Treatment Outcome

Substances

  • Acitretin